Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 579054, 7 pages
http://dx.doi.org/10.1155/2014/579054
Research Article

Water Extract of Fructus Hordei Germinatus Shows Antihyperprolactinemia Activity via Dopamine D2 Receptor

1Department of Pharmacy, The Third Hospital of Wuhan, Wuhan, Hubei 430060, China
2College of Pharmacy, Hubei University of Traditional Chinese Medicine, Wuhan, Hubei 430065, China

Received 12 May 2014; Revised 29 July 2014; Accepted 14 August 2014; Published 28 August 2014

Academic Editor: Seung-Heon Hong

Copyright © 2014 Xiong Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Lee, Y. Oh, B. Yoon, and D. Choi, “Prevalence of hyperprolactinemia in adolescents and young women with menstruation-related problems,” The American Journal of Obstetrics and Gynecology, vol. 206, no. 3, pp. 213.e1–213.e5, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. B. M. K. Biller, A. Luciano, P. G. Crosignani et al., “Guidelines for the diagnosis and treatment of hyperprolactinemia,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 44, no. 12, pp. 1075–1084, 1999. View at Google Scholar · View at Scopus
  3. M. E. Greer, T. Moraczewski, and J. S. Rakoff, “Prevalence of hyperprolactinemia in anovulatory women,” Obstetrics and Gynecology, vol. 56, no. 1, pp. 65–69, 1980. View at Google Scholar · View at Scopus
  4. G. Lutz, “Hair loss and hyperprolactinemia in women,” Dermato-Endocrinology, vol. 4, no. 1, pp. 70–76, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Yu-Lee, G. Luo, M. L. Book, and S. M. Morris, “Lactogenic hormone signal transduction,” Biology of Reproduction, vol. 58, no. 2, pp. 295–301, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Webster, G. Piscitelli, A. Polli, C. I. Ferrari, I. Ismail, and M. F. Scanlon, “A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea,” The New England Journal of Medicine, vol. 331, no. 14, pp. 904–909, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. P. M. Mah and J. Webster, “Hyperprolactinemia: etiology, diagnosis, and management,” Seminars in Reproductive Medicine, vol. 20, no. 4, pp. 365–373, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. J. Zhang, Q. R. Tan, X. C. Zhen, and Y. Tong, “The potential benefits of herbal medicines for schizophrenia :from empirical observations to clinical trials,” in Clinical Trials in Psychopharmacology, M. Hertzman and L. Adler, Eds., chapter 16, pp. 311–335, Wiley-Blackwell, Chichester, UK, 2010. View at Google Scholar
  9. W. Xiong and W. Jin-hu, “The research survey of malt,” Traditional Chinese Medicinal Materials, vol. 33, p. 1503, 2010. View at Google Scholar
  10. Z. Dong-qing, “The effect observation of malt in delactation,” Zhejiang Journal of Traditional Chinese Medicine, vol. 44, p. 883, 2010. View at Google Scholar
  11. G. Xiao-dong and G. Bin-zhang, “The effect and mechanism of different processing malt on delectation,” The Journal of North China Coal Medical University, vol. 8, pp. 658–659, 2006. View at Google Scholar
  12. W. An-hua, C. Ya-ling, and W. Jin-hu, “The effect of malt extract on prolactin levels in HPRL mice,” Herald of Medicine, vol. 28, pp. 1441–1443, 2009. View at Google Scholar
  13. W. Zhou, E.-j. Zhang, and T.-x. Gao, “The study of malt extract on hyperprol-Actinemia,” Hubei Journal of Traditional Chinese Medicine, vol. 30, pp. 10–11, 2008. View at Google Scholar
  14. P. Fitzgerald and T. G. Dinan, “Prolactin and dopamine: what is the connection?” Journal of Psychopharmacology, vol. 22, supplement 2, pp. 12–19, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. E. Demaria, G. M. Nagy, A. A. Lerant, M. I. E. Fekete, C. W. Levenson, and M. E. Freeman, “Dopamine transporters participate in the physiological regulation of prolactin,” Endocrinology, vol. 141, no. 1, pp. 366–374, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Laszczynska, S. Słuczanowska-Głabowska, M. Piasecka, J. Skowron, and T. Debinska-Szymanska, “Germ cells with nuclear DNA fragmentation related to apoptotic cells in rat testis in experimental hyperprolactinemia induced by metoclopramide,” Folia Histochemica et Cytobiologica, vol. 40, pp. 163–164, 2002. View at Google Scholar
  17. J. Dorrington and R. E. Gore-Langton, “Prolactin inhibits oestrogen synthesis in the ovary,” Nature, vol. 290, no. 5807, pp. 600–602, 1981. View at Publisher · View at Google Scholar · View at Scopus
  18. A. M. Judd, I. S. Login, K. Kovacs et al., “Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine,” Endocrinology, vol. 123, no. 5, pp. 2341–2350, 1988. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Giacomini, M. Haedo, J. Gerez et al., “Differential gene expression in models of pituitary prolactin-producing tumoral cells,” Hormone Research, vol. 71, no. 2, pp. 88–94, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Missale, L. Castelletti, F. Boroni, M. Memo, and P. Spano, “Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line,” Endocrinology, vol. 128, no. 1, pp. 13–20, 1991. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Chiasson, B. Daoust, D. Levesque, and M. Martinoli, “Dopamine D2 agonists, bromocriptine and quinpirole, increase MPP+-induced toxicity in PC12 cells,” Neurotoxicity Research, vol. 10, no. 1, pp. 31–42, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Fazeli, R. G. Oli, N. Schupp, and H. Stopper, “The role of the dopamine transporter in dopamine-induced DNA damage,” Brain Pathology, vol. 21, no. 3, pp. 237–248, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Gingrich and M. G. Caron, “Recent advances in the molecular biology of dopamine receptors,” Annual Review of Neuroscience, vol. 16, pp. 299–231, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Z. Li, J. Guo, J. Gao et al., “Role of dopamine D2 receptors in ischemia/reperfusion induced apoptosis of cultured neonatal rat cardiomyocytes,” Journal of Biomedical Science, vol. 18, article 18, 2011. View at Publisher · View at Google Scholar
  25. H. Z. Li, L. P. Han, and C. M. Jiang, “Effect of dopamine receptor-1 on apoptosis of cultured neonatal rat cardiomyocytes in simulated ischaemia/reperfusion,” Basic and Clinical Pharmacology and Toxicology, vol. 102, pp. 329–336, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Missale, S. R. Nash, S. W. Robinson, M. Jaber, and M. G. Caron, “Dopamine receptors: from structure to function,” Physiological Reviews, vol. 78, no. 1, pp. 189–225, 1998. View at Google Scholar · View at Scopus
  27. P. Greengard, “The neurobiology of slow synaptic transmission,” Science, vol. 294, no. 5544, pp. 1024–1030, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Beaulieu, R. R. Gainetdinov, and M. G. Caron, “The Akt-GSK-3 signaling cascade in the actions of dopamine,” Trends in Pharmacological Sciences, vol. 28, no. 4, pp. 166–172, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. B. K. Madras, “History of the discovery of the antipsychotic dopamine D2 receptor: a basis for the dopamine hypothesis of schizophrenia,” Journal of the History of the Neurosciences, vol. 22, no. 1, pp. 62–78, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Narkar, O. Kunduzoa, T. Hussain, C. Cambon, A. Parini, and M. Lokhandwala, “Dopamine D2-like receptor agonist bromocriptine protects against ischemia/reperfusion injury in rat kidney,” Kidney International, vol. 66, no. 2, pp. 633–640, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. M. J. Cronin, “The role and direct measurement of the dopamine receptor(s) in the anterior pituitary,” in Neuroendocrine Perspectives, E. E. Muller and R. M. MacLeod, Eds., vol. 1, pp. 169–210, 1982. View at Google Scholar
  32. C. Nilsson and E. Eriksson, “Partial dopamine D2 receptor agonists antagonize prolactin-regulating D2 receptors in a transfected clonal cell line (GH4ZR7),” European Journal of Pharmacology, vol. 218, no. 2-3, pp. 205–211, 1992. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Audinot, R. Rasolonjanahary, and B. Giros, “Couplage differentiel a la phospholi-pase C des deux isoformes du recepteur dopaminergique D2 transfectees dansla ligne GH4Cl,” Annales d Endocrinologie, vol. 52, p. 17N, 1991. View at Google Scholar